What is the current stock price of Agilent Technologies, Inc. (A)?

As of the latest market data, Agilent Technologies, Inc. (A) is trading at $115.83. The stock has seen a gain of 0.65% today.

Does Agilent Technologies, Inc. (A) pay a dividend?

Based on current data, Agilent Technologies, Inc. does not have a confirmed active dividend policy.

What is the market cap of Agilent Technologies, Inc.?

The current market capitalization of Agilent Technologies, Inc. (A) is approximately unavailable.

A

Agilent Technologies, Inc.·Healthcare

115.83

0.652%(+0.75)

Close Price

125.15

8.048%(+9.32)

After Hours

Last Updated: — ET

52W L: $108.3552W H: $160.27

A NEWS

marketbeat.com

7h ago

Agilent Technologies Q2 Earnings Call Highlights

Agilent Technologies NYSE: A raised its fiscal 2026 outlook after reporting stronger-than-expected second-quarter results, with management pointing to broad-based demand, instrument replacement momentum, pricing actions and operational gains from its Ignite operating system.

zacks.com

8h ago

Agilent (A) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for Agilent (A) give insight into how the company performed in the quarter ended April 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

zacks.com

8h ago

Agilent Technologies (A) Tops Q2 Earnings and Revenue Estimates

Agilent Technologies (A) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.4 per share. This compares to earnings of $1.31 per share a year ago.

reuters.com

10h ago

Agilent raises 2026 profit forecast on strong demand for lab tools

Life sciences firm Agilent Technologies raised its 2026 adjusted profit forecast on Wednesday, anticipating strong demand for its medical tools and ‌equipment used in lab research and diagnostic services.

businesswire.com

10h ago

Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.83 billion for the second quarter ended April 30, 2026, representing growth of 10.0% reported and up 6.3% core(1) compared with the second quarter of 2025. Second-quarter GAAP net income was $339 million, or $1.20 per share. This compares with $215 million, or $0.75 per share, in the second quarter of 2025. Non-GAAP net income(3) was $423 million, or $1.49 per share, during the quarter, compar.

gurufocus.com

1d ago

Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control

Agilent Technologies Inc. (NYSE: A) today announced the release of a new [url="]multi-attribute method (MAM)[/url] workflow designed to help pharmaceutical and

Company Profile

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Employees

17,900

IPO Date

1999-11-18

Beta

1.22

Websitewww.agilent.com↗